Pure Global

Is Low Flow Anaesthesia Feasible? - Trial NCT06389669

Access comprehensive clinical trial information for NCT06389669 through Pure Global AI's free database. This phase not specified trial is sponsored by Inonu University and is currently Not yet recruiting. The study focuses on Anesthesia. Target enrollment is 600 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06389669
Not yet recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT06389669
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Is Low Flow Anaesthesia Feasible?
Low Flow Anaesthesia is Good But Feasible?

Study Focus

Anesthesia

Observational

Sponsor & Location

Inonu University

Malatya, Turkey

Timeline & Enrollment

N/A

May 15, 2024

Sep 15, 2024

600 participants

Primary Outcome

Feasibility of Low Flow Anaesthesia

Summary

Although low-flow anaesthesia (LFA) has been described for many years and its benefits are
 known, its clinical use has been limited. Concerns about the risk of hypoxia contributed to
 this situation. Although the risk of hypoxia is almost prevented with advanced anaesthesia
 machines, the use of LFA has not reached the desired levels. However, in recent years, as
 adverse developments related to climate change have started to affect us all, LFA has started
 to be on the agenda of anaesthetists again. In this study, our aim is to examine the
 feasibility of its clinical use in order to popularise the use of LFA.

ICD-10 Classifications

Anaesthetic, unspecified
Other and unspecified general anaesthetics
Local anaesthetics
Other complications of anaesthesia
Complication of anaesthesia during labour and delivery, unspecified

Data Source

ClinicalTrials.gov

NCT06389669

Non-Device Trial